119 related articles for article (PubMed ID: 8292737)
1. Serum antibodies from halothane hepatitis patients react with the rat endoplasmic reticulum protein ERp72.
Pumford NR; Martin BM; Thomassen D; Burris JA; Kenna JG; Martin JL; Pohl LR
Chem Res Toxicol; 1993; 6(5):609-15. PubMed ID: 8292737
[TBL] [Abstract][Full Text] [Related]
2. Association of anti-58 kDa endoplasmic reticulum antibodies with halothane hepatitis.
Martin JL; Reed GF; Pohl LR
Biochem Pharmacol; 1993 Oct; 46(7):1247-50. PubMed ID: 8216376
[TBL] [Abstract][Full Text] [Related]
3. Halothane hepatitis patients have serum antibodies that react with protein disulfide isomerase.
Martin JL; Kenna JG; Martin BM; Thomassen D; Reed GF; Pohl LR
Hepatology; 1993 Oct; 18(4):858-63. PubMed ID: 8406360
[TBL] [Abstract][Full Text] [Related]
4. Human anti-endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesterase.
Satoh H; Martin BM; Schulick AH; Christ DD; Kenna JG; Pohl LR
Proc Natl Acad Sci U S A; 1989 Jan; 86(1):322-6. PubMed ID: 2911577
[TBL] [Abstract][Full Text] [Related]
5. Processing of endoplasmic reticulum luminal antigens associated with halothane hepatitis in rat hepatocytes.
Amouzadeh HR; Pohl LR
Hepatology; 1995 Sep; 22(3):936-43. PubMed ID: 7657302
[TBL] [Abstract][Full Text] [Related]
6. UDP-glucose:glycoprotein glucosyltransferase associates with endoplasmic reticulum chaperones and its activity is decreased in vivo by the inhalation anesthetic halothane.
Amouzadeh HR; Bourdi M; Martin JL; Martin BM; Pohl LR
Chem Res Toxicol; 1997 Jan; 10(1):59-63. PubMed ID: 9074803
[TBL] [Abstract][Full Text] [Related]
7. Antibody assays for the detection of patients sensitized to halothane.
Martin JL; Kenna JG; Pohl LR
Anesth Analg; 1990 Feb; 70(2):154-9. PubMed ID: 2301746
[TBL] [Abstract][Full Text] [Related]
8. The topography of trifluoroacetylated protein antigens in liver microsomal fractions from halothane treated rats.
Kenna JG; Martin JL; Pohl LR
Biochem Pharmacol; 1992 Aug; 44(4):621-9. PubMed ID: 1510711
[TBL] [Abstract][Full Text] [Related]
9. The lipoic acid containing components of the 2-oxoacid dehydrogenase complexes mimic trifluoroacetylated proteins and are autoantigens associated with halothane hepatitis.
Frey N; Christen U; Jenö P; Yeaman SJ; Shimomura Y; Kenna JG; Gandolfi AJ; Ranek L; Gut J
Chem Res Toxicol; 1995; 8(5):736-46. PubMed ID: 7548757
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting the expression of trifluoroacetylated liver microsomal protein neoantigens in rats treated with halothane.
Kenna JG; Martin JL; Satoh H; Pohl LR
Drug Metab Dispos; 1990; 18(5):788-93. PubMed ID: 1981738
[TBL] [Abstract][Full Text] [Related]
11. Metabolic basis for a drug hypersensitivity: antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane.
Kenna JG; Satoh H; Christ DD; Pohl LR
J Pharmacol Exp Ther; 1988 Jun; 245(3):1103-9. PubMed ID: 3385639
[TBL] [Abstract][Full Text] [Related]
12. Interindividual variability in P450-dependent generation of neoantigens in halothane hepatitis.
Eliasson E; Gardner I; Hume-Smith H; de Waziers I; Beaune P; Kenna JG
Chem Biol Interact; 1998 Nov; 116(1-2):123-41. PubMed ID: 9877205
[TBL] [Abstract][Full Text] [Related]
13. Halothane-induced liver injury in outbred guinea pigs: role of trifluoroacetylated protein adducts in animal susceptibility.
Bourdi M; Amouzadeh HR; Rushmore TH; Martin JL; Pohl LR
Chem Res Toxicol; 2001 Apr; 14(4):362-70. PubMed ID: 11304124
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis.
Eliasson E; Kenna JG
Mol Pharmacol; 1996 Sep; 50(3):573-82. PubMed ID: 8794896
[TBL] [Abstract][Full Text] [Related]
15. Sera from patients with halothane hepatitis contain antibodies to halothane-induced liver antigens which are not detectable by immunoblotting.
Knight TL; Scatchard KM; Van Pelt FN; Kenna JG
J Pharmacol Exp Ther; 1994 Sep; 270(3):1325-33. PubMed ID: 7932186
[TBL] [Abstract][Full Text] [Related]
16. Screening for antibodies associated with halothane hepatitis.
Hastings KL; Thomas C; Hubbard AK; Gandolfi AJ
Br J Anaesth; 1991 Dec; 67(6):722-8. PubMed ID: 1768541
[TBL] [Abstract][Full Text] [Related]
17. Absence of anti-trifluoroacetate antibody after halothane anaesthesia in patients exhibiting no or mild liver damage.
Sakaguchi Y; Inaba S; Irita K; Sakai H; Nawata H; Takahashi S
Can J Anaesth; 1994 May; 41(5 Pt 1):398-403. PubMed ID: 8055607
[TBL] [Abstract][Full Text] [Related]
18. Molecular mimicry of trifluoroacetylated human liver protein adducts by constitutive proteins and immunochemical evidence for its impairment in halothane hepatitis.
Gut J; Christen U; Huwyler J; Bürgin M; Kenna JG
Eur J Biochem; 1992 Dec; 210(2):569-76. PubMed ID: 1459138
[TBL] [Abstract][Full Text] [Related]
19. The calcium-binding protein calreticulin is covalently modified in rat liver by a reactive metabolite of the inhalation anesthetic halothane.
Butler LE; Thomassen D; Martin JL; Martin BM; Kenna JG; Pohl LR
Chem Res Toxicol; 1992; 5(3):406-10. PubMed ID: 1504264
[TBL] [Abstract][Full Text] [Related]
20. A metabolite of halothane covalently binds to an endoplasmic reticulum protein that is highly homologous to phosphatidylinositol-specific phospholipase C-alpha but has no activity.
Martin JL; Pumford NR; LaRosa AC; Martin BM; Gonzaga HM; Beaven MA; Pohl LR
Biochem Biophys Res Commun; 1991 Jul; 178(2):679-85. PubMed ID: 1650195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
